Theravance Biopharma, Inc. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Theravance Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Theravance Biopharma, Inc. for February 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 33.78 | 10,397 | 351,211 | 173,935 | 184.3 K to 173.9 K (-5.64 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 33.78 | 33,264 | 1,123,658 | 870,135 | 903.4 K to 870.1 K (-3.68 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 33.78 | 12,440 | 420,223 | 188,282 | 200.7 K to 188.3 K (-6.20 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 33.78 | 10,030 | 338,813 | 162,347 | 172.4 K to 162.3 K (-5.82 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP Global Head Acu ... | Payment of Exercise | F | 33.78 | 8,762 | 295,980 | 219,118 | 227.9 K to 219.1 K (-3.85 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 33.78 | 9,611 | 324,660 | 225,071 | 234.7 K to 225.1 K (-4.10 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 33.78 | 10,138 | 342,462 | 170,490 | 180.6 K to 170.5 K (-5.61 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 33.78 | 14,434 | 487,581 | 177,471 | 191.9 K to 177.5 K (-7.52 %) |
Feb 22 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 33.78 | 10,211 | 344,928 | 226,350 | 236.6 K to 226.4 K (-4.32 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 9,000 | 0 | 184,332 | 175.3 K to 184.3 K (+5.13 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 903,399 | 875.4 K to 903.4 K (+3.20 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 9,000 | 0 | 200,722 | 191.7 K to 200.7 K (+4.69 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 9,000 | 0 | 172,377 | 163.4 K to 172.4 K (+5.51 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP Global Head Acu ... | Grant | A | 0.00 | 9,000 | 0 | 227,880 | 218.9 K to 227.9 K (+4.11 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Grant | A | 0.00 | 9,000 | 0 | 180,628 | 171.6 K to 180.6 K (+5.24 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 9,000 | 0 | 191,905 | 182.9 K to 191.9 K (+4.92 %) |
Feb 08 2017 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 9,000 | 0 | 236,561 | 227.6 K to 236.6 K (+3.95 %) |